Nebenwirkungen · Tookad
TOOKAD 183 mg powder for solution for injection TOOKAD 366 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 8–9
HOS-136021 · Präparat HOS-097808
8 System organ class Frequency Adverse reaction Reproductive system and Very common Perineal pain9 breast disorders Male sexual dysfunction10 Common Prostatitis Genital pain11 Prostatic pain12 Haematospermia Uncommon Genital haemorrhage Penile swelling13 Prostatic haemorrhage Testicular swelling General disorders and Common Fatigue administration site conditions Uncommon Asthenia Catheter site pain Laser device failure Infusion site bruising Nodule Pain Application site erythema Investigations Common Abnormal clotting14 Uncommon Blood lactate dehydrogenase increased Blood triglyceride increased Gamma-glutamyltransferase increased Blood cholesterol increased Blood creatine phosphokinase increased Blood potassium decreased Low density lipoprotein increased Neutrophil count increased PSA increased Weight decreased White blood cell count increased Injury, poisoning and Common Perineal injury15 procedural complications Uncommon Surgical procedure repeated Contusion Post-procedural urine leak Procedural pain Post-procedural discharge Fall
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-12-07T01:00:00Z · SHA-256 86ab6205066703c9c0efe5f9fcb6f836848dd067cf287be0e096ac7a8110e9b4 · Passage bab87bcf19c113528fff16fd1f9b9f32fd36d00cc0d9cef7db9d8ca6690e0d33 · Zeichen 4610–7602 im Abschnitt